Between 2015 and 2050, the U.S. population aged 65 years and older will nearly double in size, from 48 million to 88 million and with it, the number of older American adults with cognitive impairment will surge, challenging a healthcare system that is ill-equipped to meet their related health and social needs. More than five million people in the U.S. have Alzheimer’s disease, the best known and most frequent form of cognitive impairment.1 By 2050, this number may rise to more than 13 million people. Projecting current costs and standards of care forward, annual Medicare costs related to cognitive impairment inclusive of Alzheimer’s disease will exceed one trillion dollars.2
Despite its frequency, healthcare providers currently diagnose or recognize less than half of cognitively impaired individuals, resulting in fewer opportunities for appropriate treatment and management, worse health outcomes, and escalating healthcare and psychosocial costs.3 Earlier detection of cognitive impairment has several advantages. It enables providers to identify underlying conditions that may impair cognition and improve diagnostic assessment and treatment recommendations. It also supports patient-centered care, enabling patients at risk for dementia to establish their treatment preferences when such discussions can still be accomplished. Early detection enables proactive implementation of strategies that minimize safety concerns and improve linkages for psychosocial support and community services. Moreover, detecting cognitive impairment creates the opportunity for professionals to meaningfully connect with families who often feel isolated, stigmatized, and lost, having no understanding of where to turn for help. Such caregiver connections are critical to achieving therapeutic relationships, which become even more important under such stressful circumstances. Undiagnosed cognitive impairment, on the other hand, often creates a cascade of problems, such as poor adherence with chronic disease management, onset of preventable illness, accidents and injuries at home and at work, job loss without disability support, elder abuse, and family stress and discord.
Racial and ethnic minorities and communities with low income or education are among the most vulnerable in terms of burden, delayed diagnosis, and poor management of cognitive impairment. These disparities can be further magnified by poor access to healthcare services and limited cultural competency among providers regarding beliefs, symptom presentation, and perceptions about cognitive impairment, all of which can lead to excessive delays of care until later stages of disease.4 Minority communities have among the fastest growing older adult populations, with the greatest increases being among Asian and Hispanic Americans—largely immigrant populations with varying levels of limited English proficiency.5 Reducing disparities in cognitive impairment requires use of culturally appropriate detection strategies that account for the language and social needs of the diverse communities represented in the U.S. population.
Surprisingly, despite persistent poor detection, a number of brief, evidence-based screening tools exist and are readily available for healthcare providers. Some of the more commonly used tools have been validated in multiple languages and have been widely recommended for use in the Medicare Annual Wellness Visit, which requires a brief cognitive assessment as one of a number of components. Although use of the Annual Wellness Visit has increased since its introduction and a public awareness campaign regarding cognitive impairment has become increasingly prominent, as few as 27.5% of eligible Medicare beneficiaries currently utilize this benefit,6 with lower utilization among socially disadvantaged groups.7
Then why are detection rates so poor? On the clinical front lines, most providers under diagnose cognitive impairment because of time constraints, limited training, and inexperience with screening tools.3 Cognitive impairment detection may be delayed as a result of a focus on chronic comorbid conditions and related symptoms that are common among older adults. Because of the time required to care for patients with complex and multiple chronic conditions, providers may not recognize initial signs of cognitive impairment in the context of treating other clinical priorities that may appear more immediate and pressing.8 There are also substantial cultural barriers. Family members may be reluctant to consent to diagnostic testing, as information and materials generally lack clear, culturally sensitive explanations of the symptoms associated with cognitive impairment, dementia, and Alzheimer’s disease. Often, in part because of social stigma and poor understanding of cognitive impairment symptoms, family members attribute signs of cognitive impairment to other causes, such as depression, interpersonal issues, or normal aging. Finally, there are cultural nuances across diverse communities that influence how aging and cognitive impairment is understood and supported.
Although innovative, low-cost and acceptable approaches exist to improve cognitive impairment detection across all older adult populations, culturally tailored cognitive detection paradigms are urgently needed for racial and ethnic minority communities. Collaborative care delivery models centered in primary care settings should be considered, given the need for evaluation and continuity for those who are detected. One viable approach worth testing is the use of community health workers (CHW).
By definition, CHWs are paraprofessionals who perform frontline outreach engagement to communities with which they share cultural and linguistic congruence and range from lay health workers to community health advocates to peer health professionals. Although experience with dementia has been limited in the U.S., previous work has demonstrated that CHWs can be trained as frontline detectors for dementia in resource-poor Korean American communities9 and culturally and linguistically diverse communities of Australia.10 In the authors’ own experience, CHWs have been effective in both community and clinical settings for preventing and managing diabetes, hypertension, hepatitis B, and cancer among low-income, limited English proficient Asian American communities in New York City. There is also a well-established literature on the role of peers and CHWs in substance abuse and mental health programs, conditions that are often highly stigmatizing and require trusted sources to facilitate access and retention in care.11 Building on cultural and social congruence with their clients, CHWs provide key social support and effective interpersonal communication strategies to facilitate healthful behavior change.12 These strategies have been particularly effective in reaching culturally and socioeconomically diverse patient populations and helping to shift social norms and attitudes and increase education and understanding about stigmatized conditions. In the authors’ work, they have observed how CHWs can support community capacity-building and provide place-based solutions in neighborhoods with gaps in formal resources. CHWs are uniquely positioned to improve health outcomes among immigrant and minority communities because of their valued interpersonal attributes, serving as a bridge to health and non-health resources, and often addressing social barriers to care.12
The authors envision that CHWs could potentially play a key role in helping clinical teams develop a more grounded, patient-centered understanding of barriers and facilitators to cognitive impairment detection by providing experiential-based insight that arises from culturally congruent relationships. Through their linking function, CHWs may be able to alert providers as to which of their patients are cognitively impaired and facilitate timely and appropriate care for early cognitive impairment detection. They may help to educate, activate, and navigate families to appropriate services and resources. For limited English proficient families, patient navigation via a CHW approach may be vital in removing the language and other cultural barriers to seeking care. The authors believe that testing this approach to increase detection of cognitive impairment while bridging inequities most pronounced in lower socioeconomic communities is a strategy whose time has arrived.
Acknowledgments
We thank Caroline S. Blaum, MD, Professor of Geriatrics and Population Health and Director of the Division of Geriatrics and Palliative Care at New York University (NYU) Department of Medicine; Simona Kwon, DrPH, MPH, Assistant Professor, Departments of Population Health and Medicine at NYU School of Medicine; Elaine Meyer, MS, Communications Manager, Department of Population Health at NYU School of Medicine; and Julie Kranick, MA, Project Manager, Department of Population Health at NYU School of Medicine, for their comments and support on an earlier version of this manuscript for which they were not compensated financially. We also thank Michael Mangold, MS, for his editorial assistance.
Drs. Chodosh, Thorpe, and Trinh-Shevrin each made significant contributions to the conception and design of the paper, drafting and revision for intellectual content, and approval of the final submitted version.
No financial disclosures were reported by the authors of this paper.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80(19):1778–1783. doi: 10.1212/WNL.0b013e31828726f5. https://doi.org/10.1212/WNL.0b013e31828726f5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Stefanacci RG. The costs of Alzheimer’s disease and the value of effective therapies. Am J Manag Care. 2011;17(suppl 13):S356–362. [PubMed] [Google Scholar]
- 3.Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23(4):306–314. doi: 10.1097/WAD.0b013e3181a6bebc. https://doi.org/10.1097/WAD.0b013e3181a6bebc. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chin AL, Negash S, Hamilton R. Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 2011;25(3):187–195. doi: 10.1097/WAD.0b013e318211c6c9. https://doi.org/10.1097/WAD.0b013e318211c6c9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.U. S. Census Bureau. 2014 National Population Projections. U.S. Census Bureau; 2014. [Accessed April 3, 2017]. www.census.gov/data/tables/2014/demo/popproj/2014-summary-tables.html. [Google Scholar]
- 6.Chung S, Lesser LI, Lauderdale DS, Johns NE, Palaniappan LP, Luft HS. Medicare annual preventive care visits: use increased among fee-for-service patients, but many do not participate. Health Aff (Millwood) 2015;34(1):11–20. doi: 10.1377/hlthaff.2014.0483. https://doi.org/10.1377/hlthaff.2014.0483. [DOI] [PubMed] [Google Scholar]
- 7.Ganguli I, Souza J, McWilliams JM, Mehrotra A. Trends in use of the U.S. Medicare annual wellness visit, 2011–2014. JAMA. 2017;317(21):2233–2235. doi: 10.1001/jama.2017.4342. https://doi.org/10.1001/jama.2017.4342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hinton L, Franz CE, Reddy G, Flores Y, Kravitz RL, Barker JC. Practice constraints, behavioral problems, and dementia care: primary care physicians’ perspectives. J Gen Intern Med. 2007;22(11):1487–1492. doi: 10.1007/s11606-007-0317-y. https://doi.org/10.1007/s11606-007-0317-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Han HR, Park SY, Song H, Kim M, Kim KB, Lee HB. Feasibility and validity of dementia assessment by trained community health workers based on clinical dementia rating. J Am Geriatr Soc. 2013;61(7):1141–1145. doi: 10.1111/jgs.12309. https://doi.org/10.1111/jgs.12309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Boughtwood D, Shanley C, Adams J, et al. The role of the bilingual/bicultural worker in dementia education, support and care. Dementia. 2011;12(1):7–12. doi: 10.1177/1471301211416173. https://doi.org/10.1177/1471301211416173. [DOI] [PubMed] [Google Scholar]
- 11.Barnett ML, Gonzalez A, Miranda J, Chavira DA, Lau AS. Mobilizing community health workers to address mental health disparities for underserved populations: a systematic review. Adm Policy Ment Health. doi: 10.1007/s10488-017-0815-0. In press. Online July 20, 2017. https://doi.org/10.1007/s10488-017-0815-0. [DOI] [PMC free article] [PubMed]
- 12.Islam N, Shapiro E, Wyatt L, et al. Evaluating community health workers’ attributes, roles, and pathways of action in immigrant communities. Prev Med. 2017;103:1–7. doi: 10.1016/j.ypmed.2017.07.020. https://doi.org/10.1016/j.ypmed.2017.07.020. [DOI] [PMC free article] [PubMed] [Google Scholar]